Avalyn Pharma Inc. AVLN

Set alert

26.67 USD -0.80 (-2.91%)

At closeNov 5, 2026, 4:10 PM EST

26.67 0.00 0.00%

After hours · Nov 5, 4:10 PM ET

26.26 Day range 27.97

22.24 52-week range 40.17

Held by insiders 0.00%

Held by institutions 104.08%

Float held by institutions 104.08%

Institutions 147

Top institutional holders
Holder	% held	Shares	Value	Reported
FMR, LLC	13.16%	5,835,259	155.51M	Jun 29, 2026
Novo Holdings A/S	8.76%	3,883,289	103.49M	Jun 29, 2026
SR One Capital Management, LP	7.46%	3,308,649	88.18M	Jun 29, 2026
Perceptive Advisors Llc	6.03%	2,675,296	71.30M	Jun 29, 2026
Montanova Capital LLC	5.65%	2,503,109	66.71M	Jun 29, 2026
NVP Associates, LLC	5.12%	2,268,404	60.45M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Fidelity Securities Fund-Fidelity Small Cap Growth Fund	2.78%	1,231,620	32.82M	Jul 30, 2026
Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund	1.41%	627,190	16.71M	Jul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	1.21%	534,440	14.24M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	1.05%	466,565	12.43M	Sep 29, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.	0.94%	415,610	11.08M	Jun 29, 2026
T. Rowe Price Health Sciences Fund, Inc.	0.89%	396,069	10.56M	Jun 29, 2026

AVLN insiders
Insider	Relation	Latest transaction	Date	Shares held
CARROLL JILL	Director	Purchase	Apr 30, 2026	0
FMR LLC	Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Apr 30, 2026	0
NOVO HOLDINGS A/S	Beneficial Owner of more than 10% of a Class of Security	Purchase	Apr 30, 2026	3,883,290
SR ONE CAPITAL MANAGEMENT, LLC	Beneficial Owner of more than 10% of a Class of Security	Purchase	Apr 30, 2026	0
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN II	Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	Apr 30, 2026	1,275,490

Ownership